- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1474-760X
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Pharmacogenomic analysis of patient-derived tumor cells in gynecologic cancers ; volume:20 ; number:1 ; day:26 ; month:11 ; year:2019 ; pages:1-13 ; date:12.2019
Genome biology ; 20, Heft 1 (26.11.2019), 1-13, 12.2019
- Creator
-
Sa, Jason K.
Hwang, Jae Ryoung
Cho, Young-Jae
Ryu, Ji-Yoon
Choi, Jung-Joo
Jeong, Soo Young
Kim, Jihye
Kim, Myeong Seon
Paik, E. Sun
Lee, Yoo-Young
Choi, Chel Hun
Kim, Tae-Joong
Kim, Byoung-Gie
Bae, Duk-Soo
Lee, Yeri
Her, Nam-Gu
Shin, Yong Jae
Cho, Hee Jin
Kim, Ja Yeon
Seo, Yun Jee
Koo, Harim
Oh, Jeong-Woo
Lee, Taebum
Kim, Hyun-Soo
Song, Sang Yong
Bae, Joon Seol
Park, Woong-Yang
Han, Hee Dong
Ahn, Hyung Jun
Sood, Anil K.
Rabadan, Raul
Lee, Jin-Ku
Nam, Do-Hyun
Lee, Jeong-Won
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13059-019-1848-3
- URN
-
urn:nbn:de:101:1-2020032121585236341582
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:59 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Sa, Jason K.
- Hwang, Jae Ryoung
- Cho, Young-Jae
- Ryu, Ji-Yoon
- Choi, Jung-Joo
- Jeong, Soo Young
- Kim, Jihye
- Kim, Myeong Seon
- Paik, E. Sun
- Lee, Yoo-Young
- Choi, Chel Hun
- Kim, Tae-Joong
- Kim, Byoung-Gie
- Bae, Duk-Soo
- Lee, Yeri
- Her, Nam-Gu
- Shin, Yong Jae
- Cho, Hee Jin
- Kim, Ja Yeon
- Seo, Yun Jee
- Koo, Harim
- Oh, Jeong-Woo
- Lee, Taebum
- Kim, Hyun-Soo
- Song, Sang Yong
- Bae, Joon Seol
- Park, Woong-Yang
- Han, Hee Dong
- Ahn, Hyung Jun
- Sood, Anil K.
- Rabadan, Raul
- Lee, Jin-Ku
- Nam, Do-Hyun
- Lee, Jeong-Won
- SpringerLink (Online service)
Other Objects (12)
Other Gynecologic Cancers: endometrial, ovarian, vulvar and vaginal cancers
Opportunities and challenges of patient-derived models in cancer research: patient-derived xenografts, patient-derived organoid and patient-derived cells
HOTAIR: a key regulator in gynecologic cancers
Patient-derived cell-based pharmacogenomic assessment to unveil underlying resistance mechanisms and novel therapeutics for advanced lung cancer
Targeting Patient-Derived Orthotopic Gastric Cancers with a Fluorescent Humanized Anti-CEA Antibody
Dysregulated expression of long noncoding RNAs in gynecologic cancers
Patient-derived tumor immune microenvironments in patient-derived xenografts of lung cancer
The pivotal application of patient-derived organoid biobanks for personalized treatment of gastrointestinal cancers
Risk prediction models and prevention in hormone related gynecologic cancers
The origin of patient-derived cancer organoids from pathologically undiagnosed specimen in patients with pancreatobiliary cancers
Promising preclinical patient-derived organoid (PDO) and xenograft (PDX) models in upper gastrointestinal cancers: progress and challenges
Using patient-derived tumor organoids from common epithelial cancers to analyze personalized T-cell responses to neoantigens
Other Gynecologic Cancers: endometrial, ovarian, vulvar and vaginal cancers
Opportunities and challenges of patient-derived models in cancer research: patient-derived xenografts, patient-derived organoid and patient-derived cells
HOTAIR: a key regulator in gynecologic cancers
Patient-derived cell-based pharmacogenomic assessment to unveil underlying resistance mechanisms and novel therapeutics for advanced lung cancer
Targeting Patient-Derived Orthotopic Gastric Cancers with a Fluorescent Humanized Anti-CEA Antibody
Dysregulated expression of long noncoding RNAs in gynecologic cancers
Patient-derived tumor immune microenvironments in patient-derived xenografts of lung cancer
The pivotal application of patient-derived organoid biobanks for personalized treatment of gastrointestinal cancers
Risk prediction models and prevention in hormone related gynecologic cancers
The origin of patient-derived cancer organoids from pathologically undiagnosed specimen in patients with pancreatobiliary cancers
Promising preclinical patient-derived organoid (PDO) and xenograft (PDX) models in upper gastrointestinal cancers: progress and challenges
Using patient-derived tumor organoids from common epithelial cancers to analyze personalized T-cell responses to neoantigens
Other Gynecologic Cancers: endometrial, ovarian, vulvar and vaginal cancers
Opportunities and challenges of patient-derived models in cancer research: patient-derived xenografts, patient-derived organoid and patient-derived cells
HOTAIR: a key regulator in gynecologic cancers
Patient-derived cell-based pharmacogenomic assessment to unveil underlying resistance mechanisms and novel therapeutics for advanced lung cancer
Targeting Patient-Derived Orthotopic Gastric Cancers with a Fluorescent Humanized Anti-CEA Antibody
Dysregulated expression of long noncoding RNAs in gynecologic cancers
Patient-derived tumor immune microenvironments in patient-derived xenografts of lung cancer
The pivotal application of patient-derived organoid biobanks for personalized treatment of gastrointestinal cancers
Risk prediction models and prevention in hormone related gynecologic cancers
The origin of patient-derived cancer organoids from pathologically undiagnosed specimen in patients with pancreatobiliary cancers
Promising preclinical patient-derived organoid (PDO) and xenograft (PDX) models in upper gastrointestinal cancers: progress and challenges